Un examen actualizado de la percepción de las barreras para la implementación de la farmacogenómica y la utilidad de los pares fármaco/gen en América Latina y el Caribe

La farmacogenómica (PGx) se considera un campo emergente en los países en desarrollo. La investigación sobre PGx en la región de América Latina y el Caribe (ALC) sigue siendo escasa, con información limitada en algunas poblaciones. Por lo tanto, las extrapolaciones son complicadas, especialmente en poblaciones mixtas. En este trabajo, revisamos y analizamos el conocimiento farmacogenómico entre la comunidad científica y clínica de ALC y examinamos las barreras para la aplicación clínica. Realizamos una búsqueda de publicaciones y ensayos clínicos en este campo en todo el mundo y evaluamos la contribución de ALC. A continuación, realizamos una encuesta regional estructurada que evaluó una lista de 14 barreras potenciales para la aplicación clínica de biomarcadores en función de su importancia. Además, se analizó una lista emparejada de 54 genes/fármacos para determinar una asociación entre los biomarcadores y la respuesta a la medicina genómica. Esta encuesta se comparó con una encuesta anterior realizada en 2014 para evaluar el progreso en la región. Los resultados de la búsqueda indicaron que los países de América Latina y el Caribe han contribuido con el 3,44% del total de publicaciones y el 2,45% de los ensayos clínicos relacionados con PGx en todo el mundo hasta el momento. Un total de 106 profesionales de 17 países respondieron a la encuesta. Se identificaron seis grandes grupos de obstáculos. A pesar de los continuos esfuerzos de la región en la última década, la principal barrera para la implementación de PGx en ALC sigue siendo la misma, la "necesidad de directrices, procesos y protocolos para la aplicación clínica de la farmacogenética/farmacogenómica". Las cuestiones de coste-eficacia se consideran factores críticos en la región. Los puntos relacionados con la reticencia de los clínicos son actualmente menos relevantes. Según los resultados de la encuesta, los pares gen/fármaco mejor clasificados (96%-99%) y percibidos como importantes fueron CYP2D6/tamoxifeno, CYP3A5/tacrolimus, CYP2D6/opioides, DPYD/fluoropirimidinas, TMPT/tiopurinas, CYP2D6/antidepresivos tricíclicos, CYP2C19/antidepresivos tricíclicos, NUDT15/tiopurinas, CYP2B6/efavirenz y CYP2C19/clopidogrel. En conclusión, aunque la contribución global de los países de ALC sigue siendo baja en el campo del PGx, se ha observado una mejora relevante en la región. La percepción de la utilidad de las pruebas PGx en la comunidad biomédica ha cambiado drásticamente, aumentando la concienciación entre los médicos, lo que sugiere un futuro prometedor en las aplicaciones clínicas de PGx en ALC.Pharmacogenomics (PGx) is considered an emergent field in developing countries. Research on PGx in the Latin American and the Caribbean (LAC) region remains scarce, with limited information in some populations. Thus, extrapolations are complicated, especially in mixed populations. In this paper, we reviewed and analyzed pharmacogenomic knowledge among the LAC scientific and clinical community and examined barriers to clinical application. We performed a search for publications and clinical trials in the field worldwide and evaluated the contribution of LAC. Next, we conducted a regional structured survey that evaluated a list of 14 potential barriers to the clinical implementation of biomarkers based on their importance. In addition, a paired list of 54 genes/drugs was analyzed to determine an association between biomarkers and response to genomic medicine. This survey was compared to a previous survey performed in 2014 to assess progress in the region. The search results indicated that Latin American and Caribbean countries have contributed 3.44% of the total publications and 2.45% of the PGx-related clinical trials worldwide thus far. A total of 106 professionals from 17 countries answered the survey. Six major groups of barriers were identified. Despite the region’s continuous efforts in the last decade, the primary barrier to PGx implementation in LAC remains the same, the “need for guidelines, processes, and protocols for the clinical application of pharmacogenetics/pharmacogenomics”. Cost-effectiveness issues are considered critical factors in the region. Items related to the reluctance of clinicians are currently less relevant. Based on the survey results, the highest ranked (96%–99%) gene/drug pairs perceived as important were CYP2D6/tamoxifen, CYP3A5/tacrolimus, CYP2D6/opioids, DPYD/fluoropyrimidines, TMPT/thiopurines, CYP2D6/tricyclic antidepressants, CYP2C19/tricyclic antidepressants, NUDT15/thiopurines, CYP2B6/efavirenz, and CYP2C19/clopidogrel. In conclusion, although the global contribution of LAC countries remains low in the PGx field, a relevant improvement has been observed in the region. The perception of the usefulness of PGx tests in biomedical community has drastically changed, raising awareness among physicians, which suggests a promising future in the clinical applications of PGx in LAC

Influencia de la motivación en el rendimiento laboral de los colaboradores en los hoteles de tres estrellas de la provincia de San Martín, 2019

La investigación titulada Influencia de la motivación en el rendimiento laboral de los colaboradores en los hoteles de tres estrellas de la provincia de San Martín, 2019; tuvo como objetivo general determinar la influencia de la motivación en el rendimiento laboral. El tipo de estudio fue aplicada, nivel correlacional y diseño descriptivo. La muestra estuvo conformada por 70 olaboradores de 9 hoteles de tres estrellas ubicados en la provincia de San Martín. El instrumento de recojo de información fueron cuestionarios. Los resultado demostraron que la motivación fue calificada como baja en un 53%; este resultado fue palpable por 37 de los 70 colaboradores que registran los hoteles de tres estrellas de la provincia de San Martín, así mismo esto se debió a las condiciones laborales, las cuales no fueron las más adecuadas. Por otra parte, el nivel de rendimiento laboral fue identificado como deficiente en un 59%; este resultado fue percibido por 41 de los 70 los colaboradores de los hoteles de tres estrellas de la provincia de San Martin; es aquí donde la actitud hacia el trabajo no es la correcta, así mismo este hecho viene siendo frecuente, lo cual es observable a través de la presentación personal y el desempeño laboral que determinan en sus deberes de día a día. Concluye que la motivación influyó positiva y significativamente con el rendimiento laboral de los colaboradores en los hoteles de tres estrellas de la provincia de San Martín. Así mismo, este resultado fue comprobado con la aplicación de la prueba estadística Rho de Spearman, es aquí donde el sig. (Bilateral) fue 0,000 menor al margen de error 0,05; ademas, el grado de correlacion fue positiva media de 0,683; esto hace referencia que mientras mas este motivado los colaboradores el rendimiento laboral será el esperado.The research entitled "Influence of motivation on the work performance of employees in three-star hotels in the province of San Martín, 2019"; had as general objective to determine the influence of motivation on work performance. The type of study was applied, correlational level and descriptive design. The sample was conformed by 70 collaborators of 9 hotels of three stars located in the province of San Martin. The instruments of information collection were questionnaires. The results showed that the motivation was qualified as low by 53%; this result was felt by 37 of the 70 collaborators that registered the three star hotels in the province of San Martin, likewise this was due to the working conditions, which were not the most adequate. On the other hand, the level of labor performance was identified as deficient in 59%; this result was perceived by 41 of the 70 collaborators of the three star hotels in the province of San Martin; the attitude towards work is not the correct one, likewise this fact has been frequent, which is observable through the personal presentation and work performance that they determine in their day-to-day duties. In conclusion, the motivation had a positive and significant influence on the work performance of employees in the three-star hotels in the province of San Martín. Likewise, this result was verified with the application of the statistical test Rho of Spearman, where the sig. (Bilateral) was 0,000 less than the margin of error 0,05; in addition, the degree of correlation was positive average of 0,683; which means that more motivated the collaborators are, the labor yield will be the expected one.TesisAp

Production performance of lactating dairy cows at pasture fed concentrate supplemented with licuri oil

The objective of this study was to determine the optimal level of licuri oil to use in the concentrate of lactating dairy cows on pasture, through growth performance, feed conversion and cost of the supplementation. A total of 16 dairy cows, Holstein × Zebu crossbreed, were kept on Tanzania grass pasture. Cows were divided into four Latin squares, 4 × 4, formed by four experimental periods of 21 days, divided into 17 days for adaptation and four days for data collection. Cows received three kg of concentrate per day at the time of milking, and the treatments consisted of four diets containing licuri oil at levels of 0.0, 1.5, 3.0, and 4.5% of the concentrated dry matter. There was a linear increase in the daily milk yield, corrected to 3.5% fat, and an improvement in the feed conversion of the dry matter and neutral detergent fiber with the inclusion of the licuri oil. The optimal level of licuri oil was 1.5% of the concentrated DM for dairy cows on pasture, whose level has the best profit sale of milk, with positive results in the corrected daily milk production and conversion of the feed nutrients

Notes for genera – Ascomycota

Knowledge of the relationships and thus the classification of fungi, has developed rapidly with increasingly widespread use of molecular techniques, over the past 10--15 years, and continues to accelerate. Several genera have been found to be polyphyletic, and their generic concepts have subsequently been emended. New names have thus been introduced for species which are phylogenetically distinct from the type species of particular genera. The ending of the separate naming of morphs of the same species in 2011, has also caused changes in fungal generic names. In order to facilitate access to all important changes, it was desirable to compile these in a single document. The present article provides a list of generic names of Ascomycota (approximately 6500 accepted names published to the end of 2016), including those which are lichen-forming. Notes and summaries of the changes since the last edition of `Ainsworth Bisby's Dictionary of the Fungi' in 2008 are provided. The notes include the number of accepted species, classification, type species (with location of the type material), culture availability, life-styles, distribution, and selected publications that have appeared since 2008. This work is intended to provide the foundation for updating the ascomycete component of the ``Without prejudice list of generic names of Fungi'' published in 2013, which will be developed into a list of protected generic names. This will be subjected to the XIXth International Botanical Congress in Shenzhen in July 2017 agreeing to a modification in the rules relating to protected lists, and scrutiny by procedures determined by the Nomenclature Committee for Fungi (NCF). The previously invalidly published generic names Barriopsis, Collophora (as Collophorina), Cryomyces, Dematiopleospora, Heterospora (as Heterosporicola), Lithophila, Palmomyces (as Palmaria) and Saxomyces are validated, as are two previously invalid family names, Bartaliniaceae and Wiesneriomycetaceae. Four species of Lalaria, which were invalidly published are transferred to Taphrina and validated as new combinations. Catenomycopsis Tibell Constant. is reduced under Chaenothecopsis Vain., while Dichomera Cooke is reduced under Botryosphaeria Ces. De Not. (Art. 59)